Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

67.50USD
19 Sep 2018
Change (% chg)

-- (--)
Prev Close
$67.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,318
52-wk High
$76.98
52-wk Low
$27.74

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -1.06 December 20 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 4 3
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.43 1.43 1.50 1.60

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.08 0.20 0.00 0.77
Quarter Ending Dec-18 6 0.26 1.14 0.00 0.77
Year Ending Dec-18 7 1.20 5.00 0.00 2.73
Year Ending Dec-19 6 1.78 10.00 0.00 2.17
Earnings (per share)
Quarter Ending Sep-18 6 -1.06 -0.67 -1.20 -0.70
Quarter Ending Dec-18 6 -1.13 -0.80 -1.30 -0.71
Year Ending Dec-18 7 -3.72 -3.09 -4.13 -2.75
Year Ending Dec-19 6 -3.98 -1.35 -5.29 -3.38

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.09 0.02 0.07 78.97
Quarter Ending Mar-18 0.41 0.03 0.38 93.16
Quarter Ending Dec-17 0.36 0.28 0.08 21.28
Quarter Ending Sep-17 0.62 0.43 0.18 29.48
Quarter Ending Jun-17 0.78 0.44 0.34 43.19
Earnings (per share)
Quarter Ending Jun-18 -0.90 -0.55 0.35 -38.83
Quarter Ending Mar-18 -0.76 -1.07 0.31 -41.48
Quarter Ending Dec-17 -0.81 -0.92 0.11 -13.64
Quarter Ending Sep-17 -0.74 -1.04 0.30 -41.36
Quarter Ending Jun-17 -0.73 -0.94 0.21 -29.53

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.08 0.08 0.09 0.11 0.77
Quarter Ending Dec-18 0.26 0.26 0.26 0.31 0.77
Year Ending Dec-18 1.20 1.20 2.15 2.49 2.73
Year Ending Dec-19 1.78 1.78 1.79 2.12 2.17
Earnings (per share)
Quarter Ending Sep-18 -1.06 -1.06 -0.93 -0.89 -0.70
Quarter Ending Dec-18 -1.13 -1.13 -0.97 -0.91 -0.71
Year Ending Dec-18 -3.72 -3.72 -3.81 -3.70 -2.75
Year Ending Dec-19 -3.98 -3.98 -3.91 -3.70 -3.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 1
Quarter Ending Dec-18 0 0 0 1
Year Ending Dec-18 0 0 0 5
Year Ending Dec-19 0 0 0 1
Earnings
Quarter Ending Sep-18 0 0 2 4
Quarter Ending Dec-18 0 0 2 4
Year Ending Dec-18 0 0 3 3
Year Ending Dec-19 0 0 2 3